albendazole sulfone has been researched along with albendazole sulfoxide in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.54) | 18.7374 |
| 1990's | 18 (34.62) | 18.2507 |
| 2000's | 17 (32.69) | 29.6817 |
| 2010's | 11 (21.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gascon, L; Lanusse, CE; Prichard, RK | 1 |
| Lanusse, CE; Prichard, RK | 1 |
| Chai, JJ; Jiao, PY; Wang, MJ; Xiao, SH; Yang, B; You, JQ | 1 |
| Alvinerie, M; Francheteau, P; Galtier, P; Houin, G; Plusquellec, Y; Steimer, JL | 1 |
| Lanusse, CE; Prichard, RK; Ranjan, S; Trudeau, C | 1 |
| Benoit, E; Besse, S; Boukraa, A; Delatour, P | 1 |
| Cotting, J; Zeugin, T; Zysset, T | 1 |
| Lanusse, CE; Prichard, RK; Ranjan, S | 1 |
| Eagleson, GK; Hennessy, DR; Lacey, E; Prichard, RK; Steel, JW | 1 |
| Batt, AM; Delatour, P; Masson, C; Mothe, O; Siest, G; Souhaili-El Amri, H; Totis, M | 1 |
| Bogan, JA; Dickson, B; Marriner, SE; Morris, DL | 1 |
| Fetterer, RH; Rew, RS | 1 |
| Bogan, JA; Marriner, SE; Vandaele, W | 1 |
| Bogan, JA; Marriner, SE | 1 |
| Chai, JJ; Jiao, W; Shen, BG; Xiao, SH; Yang, YQ; You, JQ | 1 |
| Alvarez, LI; Lanusse, CE; Sanchez, SF; Saumell, CA | 1 |
| Botsoglou, NA; Fletouris, DJ; Mantis, AI; Psomas, IE | 1 |
| Lanusse, C; Lifschitz, A; Mastromarino, M; Virkel, G | 1 |
| Alvarez, LI; Lanusse, CE; Sánchez, SF | 1 |
| Sanyal, PK | 1 |
| Bonato, PS; de Carvalho, R; Lanchote, VL; Marques, MP; Paias, FO; Takayanagui, OM | 1 |
| Drancourt, M; Ridoux, O | 1 |
| Bigler, P; Cavaliero, T; Gottstein, B; Hemphill, A; Ingold, K; Thormann, W | 1 |
| Bhagwan, PS; Khan, FA; Sanyal, PK; Singh, D; Swarnkar, CP | 1 |
| Chouki, M; Procházková, A; Theurillat, R; Thormann, W | 1 |
| Gottstein, B; Hemphill, A; Lawton, P; Sarciron, E; Siles-Lucas, M; Stettler, M | 1 |
| Bonato, PS; Dreossi, SA; Lanchote, VL; Takayanagui, OM | 1 |
| Dadashzadeh, S; Mirfazaelian, A; Rouini, MR | 2 |
| Bonato, PS; Lanchote, VL; Takayanagui, OM | 1 |
| Alvarez, AI; García, JL; Merino, G; Molina, AJ; Prieto, JG; Pulido, MM | 1 |
| Balarinová, R; Baliharová, V; Lamka, J; Skálová, L; Velík, J | 1 |
| Goudah, A | 1 |
| Batzias, GC; Delis, GA | 1 |
| Batzias, GC; Delis, GA; Theodosiadou, E | 1 |
| Fletouris, DJ; Nakos, DS; Papapanagiotou, EP; Psomas, IE | 1 |
| Medlicott, NJ; Razzak, M; Tucker, IG; Wu, Z | 1 |
| Bonato, PS; de Oliveira, AR; de Santana, FJ; Fernandes, BJ; Garcia, HH; Gonzalez, AE; Lanchote, VL; Takayanagui, OM | 1 |
| Chaudhary, PL; Dubey, AK; Koley, KM; Mandal, SC; Mukherjee, K; Pal, S; Sanyal, PK | 1 |
| Belaz, KR; Cass, QB; Oliveira, RV | 1 |
| Adas, G; Arikan, S; Karatepe, O; Kemik, O; Oner, A; Sahip, N | 1 |
| Girisham, S; Reddy, SM; Shyam Prasad, G | 1 |
| Grabowski, T; Jaroszewski, JJ; Markiewicz, W; Maślanka, T; Sawicka, R; Swierczewska, A; Ziółkowski, H | 1 |
| Cárdenas, G; González-Hernández, I; Jung-Cook, H; Ruiz-Olmedo, MI | 1 |
| Ai, D; Cao, J; Chen, C; Li, J; Li, Z; Qi, Y; Shen, H; Wang, C; Yi, W | 1 |
| Barth, T; Borges, KB; Carrão, DB; de Oliveira, AR; Furtado, NA; Hilário, VC; Pupo, MT | 1 |
| Alvarez, L; Bistoletti, M; Lanusse, C; Moreno, L | 1 |
| Li, L; Li, QR; Xiao, Y; Xing, DX; Yang, Q; Ye, MQ | 1 |
| Belaz, KR; da Silva, CA; de O Cardoso, J; Oliveira, RV | 1 |
| Busatto, Z; da Silva, AF; de Freitas, O; Paschoal, JA | 1 |
| Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR | 1 |
| Donnelly, RF; McCarthy, HO; Permana, AD; Tekko, IA | 1 |
1 trial(s) available for albendazole sulfone and albendazole sulfoxide
| Article | Year |
|---|---|
Time dependent pharmacokinetics of albendazole in human.
Topics: Administration, Oral; Adult; Albendazole; Anthelmintics; Area Under Curve; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Liver; Male; Time Factors | 2003 |
51 other study(ies) available for albendazole sulfone and albendazole sulfoxide
| Article | Year |
|---|---|
Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, High Pressure Liquid; Female; Guanidines; Injections, Intramuscular; Methimazole; Sheep | 1992 |
Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, High Pressure Liquid; Drug Interactions; Guanidines; Injections, Intramuscular; Male; Methimazole; Sheep | 1992 |
[Pharmacokinetics of four benzimidazoles administered intragastrically to mice infected with secondary cysts of Echinococcus granulosus].
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Female; Mebendazole; Mice; Stomach | 1991 |
Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheep.
Topics: Administration, Oral; Albendazole; Animals; Injections; Injections, Intravenous; Male; Mathematics; Metabolic Clearance Rate; Models, Biological; Molecular Structure; Rumen; Sheep | 1991 |
Pharmacokinetic profiles of netobimin metabolites after oral administration of zwitterion and trisamine formulations of netobimin to cattle.
Topics: Administration, Oral; Albendazole; Animals; Cattle; Guanidines; Male; Tromethamine | 1991 |
Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
Topics: Albendazole; Animals; Chromatography, High Pressure Liquid; Dogs; Humans; Kinetics; Male; Rats; Rats, Inbred Strains; Stereoisomerism | 1991 |
Therapeutic monitoring of albendazole: a high-performance liquid chromatography method for determination of its active metabolite albendazole sulfoxide.
Topics: Albendazole; Chromatography, High Pressure Liquid; Humans; Monitoring, Physiologic | 1990 |
Comparison of pharmacokinetic variables for two injectable formulations of netobimin administered to calves.
Topics: Albendazole; Animals; Cattle; Chemistry, Pharmaceutical; Guanidines; Half-Life; Injections, Subcutaneous; Time Factors | 1990 |
The disposition of albendazole in sheep.
Topics: Albendazole; Animals; Bile; Male; Molecular Structure; Sheep | 1989 |
Albendazole sulfonation by rat liver cytochrome P-450c.
Topics: Albendazole; Animals; Anthelmintics; Aroclors; Benzimidazoles; Biotransformation; Chlorodiphenyl (54% Chlorine); Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Male; Methylcholanthrene; Microsomes, Liver; Rats; Rats, Inbred Strains; Safrole | 1988 |
Pharmacokinetics of albendazole in man.
Topics: Absorption; Adipose Tissue; Adult; Albendazole; Anthelmintics; Benzimidazoles; Echinococcosis; Female; Humans; Kinetics; Male | 1986 |
Interaction of Fasciola hepatica with albendazole and its metabolites.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Carbon Dioxide; Cattle; Fasciola hepatica; Glucose; Oxidation-Reduction; Sheep | 1984 |
Comparison of the pharmacokinetics of albendazole and its major metabolites after oral administration of albendazole as a suspension and as a paste formulation to sheep.
Topics: Abomasum; Administration, Oral; Albendazole; Animals; Benzimidazoles; Kinetics; Ointments; Rumen; Sheep; Suspensions; Time Factors | 1981 |
Pharmacokinetics of albendazole in sheep.
Topics: Abomasum; Albendazole; Animals; Benzimidazoles; Female; Male; Sheep; Sulfones; Sulfoxides | 1980 |
Effects of benzimidazole compounds on mice infected with secondary cysts of Echinococcus granulosus.
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Echinococcus; Female; In Vitro Techniques; Mebendazole; Mice | 1994 |
Plasma disposition kinetics of albendazole metabolites in pigs fed different diets.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Diet; Dietary Proteins; Female; Food, Fortified; Male; Milk Proteins; Poaceae; Swine; Time Factors; Whey Proteins | 1996 |
Trace analysis of albendazole and its sulphoxide and sulphone metabolites in milk by liquid chromatography.
Topics: Albendazole; Animals; Anthelmintics; Cattle; Chromatography, Liquid; Feasibility Studies; Female; Milk; Reproducibility of Results; Sensitivity and Specificity; Sulfones; Sulfoxides | 1996 |
Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Fasting; Female; Random Allocation; Sheep; Time Factors | 1997 |
Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
Topics: Abomasum; Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Haemonchiasis; Half-Life; Male; Sheep; Sheep Diseases | 1997 |
The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
Topics: Albendazole; Animals; Anthelmintics; Anticestodal Agents; Buffaloes; Cattle; Drug Administration Schedule; Injections; Male; Metabolic Clearance Rate; Rumen | 1998 |
Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma.
Topics: Albendazole; Antiparasitic Agents; Chromatography, High Pressure Liquid; Cysticercosis; Humans; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 1998 |
In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Encephalitozoon; Encephalitozoon cuniculi; Fibroblasts; Humans | 1998 |
Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Echinococcosis; Echinococcus; Microscopy, Electron | 1999 |
Influence of diet type and pretreatment fasting on the disposition kinetics of albendazole in sheep.
Topics: Albendazole; Animal Feed; Animals; Anthelmintics; Biological Availability; Diet; Eating; Fasting; Metabolic Clearance Rate; Poaceae; Sheep | 1999 |
Therapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis.
Topics: Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Drug Monitoring; Electrophoresis, Capillary; Humans; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone.
Topics: Albendazole; Alkaline Phosphatase; Animals; Anthelmintics; Biomarkers; Echinococcus; Immunohistochemistry; In Vitro Techniques; Microscopy, Electron, Scanning | 2001 |
Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Female; Humans; Male; Middle Aged; Neurocysticercosis; Stereoisomerism | 2002 |
Effect of gender in the disposition of albendazole metabolites in humans.
Topics: Administration, Oral; Adult; Albendazole; Area Under Curve; Double-Blind Method; Female; Half-Life; Humans; Male; Sex Factors | 2002 |
Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma.
Topics: Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Antifungal Agents; Area Under Curve; Biotransformation; Clotrimazole; Drug Interactions; Half-Life; Liver; Male; Rats; Rats, Wistar | 2003 |
The effects of albendazole and its metabolites on hepatic cytochromes P450 activities in mouflon and rat.
Topics: Albendazole; Animals; Anthelmintics; Blotting, Western; Cytochrome P-450 Enzyme System; Enzyme Induction; Formazans; Hepatocytes; Isoenzymes; Male; Microsomes, Liver; Rats; Sheep, Domestic; Tetrazolium Salts | 2003 |
Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Female; Half-Life; Sheep; Stereoisomerism | 2003 |
Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma.
Topics: Albendazole; Animals; Anthelmintics; Calibration; Chromatography, High Pressure Liquid; Sensitivity and Specificity; Sheep; Spectrometry, Fluorescence | 2004 |
Quantitative determination of albendazole metabolites in sheep spermatozoa and seminal plasma by liquid chromatographic analysis with fluorescence detection.
Topics: Albendazole; Animals; Anthelmintics; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Freezing; Male; Molecular Structure; Semen; Sheep; Spermatozoa | 2004 |
Highly sensitive ion pair liquid chromatographic determination of albendazole marker residue in animal tissues.
Topics: Adipose Tissue; Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Kidney; Liver; Muscles; Pesticide Residues; Quality Control; Sensitivity and Specificity; Sheep | 2005 |
Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma.
Topics: Albendazole; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Quantitative Structure-Activity Relationship; Reference Standards; Reproducibility of Results; Sheep | 2005 |
Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Biotransformation; Chromatography, High Pressure Liquid; Indicators and Reagents; Praziquantel; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Swine | 2007 |
Kinetic disposition of albendazole in goats subclinically infected with gastrointestinal nematodes vis-à-vis naive animals following oral and intraruminal administration.
Topics: Administration, Oral; Albendazole; Animals; Animals, Domestic; Antinematodal Agents; Biological Availability; Feces; Female; Goat Diseases; Goats; Half-Life; Nematoda; Nematode Infections; Parasite Egg Count; Rumen | 2008 |
Determination of albendazole metabolites by direct injection of bovine plasma and multidimensional achiral-chiral high performance liquid chromatography.
Topics: Albendazole; Animals; Cattle; Chromatography, High Pressure Liquid; Injections; Polysaccharides; Reproducibility of Results; Stereoisomerism | 2008 |
Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study).
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis, Hepatic; Echinococcus granulosus; Humans; In Vitro Techniques; Solutions | 2009 |
Microbial transformation of albendazole.
Topics: Albendazole; Anthelmintics; Biotransformation; Gram-Negative Bacteria | 2010 |
Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys.
Topics: Albendazole; Animals; Anthelmintics; Area Under Curve; Chromatography, High Pressure Liquid; Drug Stability; Female; Least-Squares Analysis; Liquid-Liquid Extraction; Reproducibility of Results; Sensitivity and Specificity; Turkeys | 2011 |
A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.
Topics: Albendazole; Anthelmintics; Chromatography, Liquid; Drug Stability; Humans; Linear Models; Neurocysticercosis; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Biotransformation; Carps; Chromatography, High Pressure Liquid; Drug Residues; Half-Life; Metabolic Clearance Rate; Models, Biological; Reproducibility of Results; Spectrophotometry, Ultraviolet; Temperature; Tissue Distribution | 2012 |
Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode.
Topics: Albendazole; Ascomycota; Biotransformation; Chromatography, High Pressure Liquid; Stereoisomerism | 2012 |
Effects of feeding on the plasma disposition kinetics of the anthelmintic albendazole in laying hens.
Topics: Albendazole; Animals; Anthelmintics; Chickens; Diet; Female; Food Deprivation | 2014 |
Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography tandem triple quadrupole mass spectrometry.
Topics: Albendazole; Analytic Sample Preparation Methods; Animals; Antiparasitic Agents; Bombyx; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Freezing; Hemolymph; Limit of Detection; Linear Models; Liquid-Liquid Extraction; Tandem Mass Spectrometry; Time Factors | 2014 |
The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats.
Topics: Albendazole; Animal Nutritional Physiological Phenomena; Animals; Biotransformation; Diet, Protein-Restricted; Disease Models, Animal; Liver; Male; Microsomes, Liver; Nutritional Status; Oxidation-Reduction; Protein-Energy Malnutrition; Rats, Wistar | 2015 |
LC-MS/MS methods for albendazole analysis in feed and its metabolite residues in fish fillet and a leaching study in feed after an alternative procedure for drug incorporation.
Topics: Albendazole; Animal Feed; Animals; Anthelmintics; Biotransformation; Brazil; Cellulose; Characiformes; Chromatography, Liquid; Coated Materials, Biocompatible; Drug Liberation; Drug Residues; Guidelines as Topic; Humans; Kinetics; Limit of Detection; Liquid-Liquid Extraction; Meat; Tandem Mass Spectrometry | 2017 |
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole | 2018 |
New HPLC-MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration.
Topics: Administration, Oral; Albendazole; Animals; Chromatography, High Pressure Liquid; Diethylcarbamazine; Doxycycline; Plasma; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2019 |